Researchers at VHIO have published an article in the journal European Journal of Cancer on the evolution of targeted therapies…
Elena Garralda
VHIO played a prominent role at the ESMO Targeted Anticancer Therapies (TAT) congress, one of the leading international forums in…
Co-led by Rodrigo Toledo and Elena Garralda, IMMUNOMICS-VHIO is a platform for the discovery and validation of liquid biopsy biomarkers…
Engineering T cells directly inside the patient’s body to turn them into CAR-T cells ready to attack tumor cells, using…
Reported at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany, results from four multicenter early phase…
VHIO cordinates the EU-funded PragmaTIL project. funded by the EU. The initiative brings together 12 institutions from 6 countries with…
Co-authored by leading experts in oncology, a review article recently published in the Journal of Clinical Oncology (JCO)* provides an…
Published in the journal Nature Communications*, results from a first-in-human, phase I clinical trial of an oral, potent and reversible…
The journal Nature has published the results of a clinical trial led by researchers from the Clínica Universidad de Navarra…
Co-authored by investigators of VHIO’s Cancer Genomics Group and Research Unit for Molecular Therapy of Cancer (UITM) – CaixaResearch, results…
